Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

OP-1 role in kidney formation investigated

Aug. 30, 1996

Taisho discloses agents for urinary incontinence

Aug. 30, 1996

Reliance approved for marketing in U.S.

Aug. 30, 1996

Potential BPH therapeutics from Poli Industria Chimica

Aug. 30, 1996

U.S. agreement announced for ProstaFlo

Aug. 30, 1996

Terazosin and finasteride go head-to-head in BPH patients

Aug. 30, 1996

McGill University researchers improve safety of cell therapy

Aug. 23, 1996

Bioniche seeks U.S. approval to begin Cystistat clinical trials

Aug. 23, 1996

Boston Scientific to distribute Urologix technology

Aug. 23, 1996

EDAP signs license agreement for microwave technology

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.